Emerging Real-World Midostaurin Treatment Patterns and Outcomes in FLT3-Mutated Acute Myeloid Leukemia at a Comprehensive Cancer Center

被引:0
作者
Willis, Connor [1 ]
Menon, Jyothi [1 ]
Unni, Sudhir [1 ]
Au, Trang [1 ]
Ndife, Briana [2 ]
Joseph, George J. [2 ]
Bonifacio, Gaetano J. [3 ]
Stein, Eytan M. [4 ]
Tantravahi, Srinivas K. [5 ]
Shami, Paul J. [6 ]
Kovacsovics, Tibor [6 ]
Brixner, Diana [1 ]
Stenehjem, David Dean [1 ]
机构
[1] Univ Utah, Dept Pharmacotherapy, Salt Lake City, UT USA
[2] Novartis Pharmaceut, E Hanover, NJ USA
[3] Novartis, Conshohocken, NJ USA
[4] Mem Sloan Kettering Canc Ctr, Leukemia Serv, Div Hematol Oncol, 1275 York Ave, New York, NY 10021 USA
[5] Univ Utah, Huntsman Canc Inst, Salt Lake City, UT USA
[6] Univ Utah, Huntsman Canc Inst, Div Hematol & Hematol Malignancies, Salt Lake City, UT USA
关键词
D O I
10.1182/blood-2018-99-115009
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
4745
引用
收藏
页数:3
相关论文
empty
未找到相关数据